Immunocore Ownership | Who Owns Immunocore?

Overview Forecast RevenueFinancials Chart Transcripts

Immunocore Ownership Summary

Immunocore is owned by 41.08% institutional investors, 5.24% insiders, and 53.69% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 13.39% of IMCR shares. Vanguard Health Care Inv is the top mutual fund, with 9.16% of its assets in Immunocore shares.

IMCR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunocore	41.08%	5.24%	53.69%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
T. rowe price investment management	6.70M	13.39%	$197.66M
Wellington management group llp	6.62M	13.23%	$195.20M
Rtw investments, lp	4.87M	9.74%	$143.66M
Fmr	4.82M	9.63%	$142.12M
Primecap management co/ca/	2.67M	5.33%	$78.72M
Price t rowe associates inc /md/	2.19M	4.37%	$64.53M
Tang capital management	1.56M	3.11%	$45.89M
Baker bros. advisors lp	1.52M	3.03%	$44.70M
General atlantic	1.26M	2.52%	$37.22M
Kynam capital management, lp	1.23M	2.45%	$36.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tang capital management	1.56M	3.04%	$45.89M
Rtw investments, lp	4.87M	2.17%	$143.66M
Kynam capital management, lp	1.23M	2.14%	$36.15M
General atlantic	1.26M	1.32%	$37.22M
Bellevue group	1.21M	0.68%	$35.56M
Deep track capital, lp	519.38K	0.57%	$15.32M
Armistice capital	1.20M	0.48%	$35.40M
Baker bros. advisors lp	1.52M	0.48%	$44.70M
Eagle health investments lp	46.30K	0.33%	$1.37M
Rhenman & partners asset management ab	58.28K	0.18%	$1.72M

Top Buyers

Holder	Shares	% Assets	Change
Kynam capital management, lp	1.23M	2.14%	1.23M
Citigroup	632.94K	0.01%	616.91K
Groupama asset managment	600.00K	0.01%	600.00K
Deep track capital, lp	519.38K	0.57%	519.38K
Tang capital management	1.56M	3.04%	450.00K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-1.79M
Logos global management lp	-	-	-900.00K
Braidwell lp	-	-	-797.27K
Pictet asset management sa	-	-	-706.61K
Blackrock funding, inc. /de	272.78K	0.00%	-600.83K

New Positions

Holder	Shares	% Assets	Change	Value
Kynam capital management, lp	1.23M	2.14%	1.23M	$36.15M
Groupama asset managment	600.00K	0.01%	600.00K	$510.31K
Deep track capital, lp	519.38K	0.57%	519.38K	$15.32M
Point72 asset management	403.30K	0.03%	403.30K	$11.90M
Bnp paribas arbitrage, snc	193.12K	0.00%	193.12K	$5.70M

Sold Out

Holder	Change
J.safra asset management	-5.00
Nelson, van denburg & campbell wealth management group	-6.00
Geneos wealth management	-11.00
Cva family office	-22.00
Park place capital	-29.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	76	-45.71%	20,547,400	-54.62%	41	0.50%	28	-57.58%	28	-26.32%
Sep 30, 2024	138	-6.76%	45,248,455	3.71%	90	1.18%	64	-23.81%	37	15.63%
Jun 30, 2024	145	-9.94%	43,628,132	5.90%	87	1231365.60%	82	-9.89%	31	-27.91%
Mar 31, 2024	161	10.27%	41,196,539	9.88%	-	0.00%	91	15.19%	43	2.38%
Dec 31, 2023	146	11.45%	37,492,758	1.55%	76	1.33%	79	25.40%	42	5.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	4.58M	9.16%	-
T. Rowe Price US Small-Cap Core Equity	1.86M	3.77%	126.24K
T. Rowe Price Small-Cap Stock	1.86M	3.77%	-402.00
Vanguard Capital Opportunity Inv	1.75M	3.50%	130.33K
Fidelity Growth Compy Commingled Pl S	1.28M	2.60%	13.72K
T. Rowe Price Small-Cap Value	1.26M	2.55%	-270.00
BB Biotech AG Ord	1.21M	2.41%	-
Fidelity Growth Compy Commingled Pl O	1.15M	2.30%	101.00
T. Rowe Price Instl Small-Cap Stock	992.50K	2.01%	-
T. Rowe Price Health Sciences	916.57K	1.86%	-101.42K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 17, 2025	BAKER BROS. ADVISORS LP	-	Buy	$1.79M
Mar 17, 2025	BAKER BROS. ADVISORS LP	-	Buy	$253.89K
Mar 17, 2025	BAKER BROS. ADVISORS LP	-	Buy	$19.22M
Mar 17, 2025	BAKER BROS. ADVISORS LP	-	Buy	$2.73M
Mar 17, 2025	BAKER BROS. ADVISORS LP	-	Sell	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	4	1
2024 Q2	-	1
2024 Q1	-	12

IMCR Ownership FAQ

Who Owns Immunocore?

Immunocore shareholders are primarily institutional investors at 41.08%, followed by 5.24% insiders and 53.68% retail investors. The average institutional ownership in Immunocore's industry, Biotech Stocks , is 68.48%, which Immunocore falls below.

Who owns the most shares of Immunocore?

Immunocore’s largest shareholders are T. rowe price investment management (6.7M shares, 13.39%), Wellington management group llp (6.62M shares, 13.23%), and Rtw investments, lp (4.87M shares, 9.74%). Together, they hold 36.36% of Immunocore’s total shares outstanding.

Does Blackrock own Immunocore?

BlackRock is not among the top 10 institutional shareholders of Immunocore.

Who is Immunocore’s biggest shareholder by percentage of total assets invested?

Tang capital management is Immunocore’s biggest shareholder by percentage of total assets invested, with 3.04% of its assets in 1.56M Immunocore shares, valued at 45.89M$.

Who is the top mutual fund holder of Immunocore shares?

Vanguard Health Care Inv is the top mutual fund holder of Immunocore shares, with 9.16% of its total shares outstanding invested in 4.58M Immunocore shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools